| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 5867 | QASTDAGTAGALTPQHVR | S | 3 | 109 |
| 10006090 | AMLSQMNVTAPTSPPVQQNMMNSASGPLPDGWEQAMTQDGEIYYINHK | T | 37 | 241 |
| 10006105 | TANVPQTVPMR | T | 7 | 83 |
| 10006106 | QASTDAGTAGALTPQHVR | S | 3 | 109 |
| 10006107 | SQLPTLEQDGGT QNPVSSPGMSQELR | S | 1 | 350 |
| 10014834 | TANVPQTVPMR | T | 7 | 83 |
| 10014888 | NINPSTANSPK | S | 5 | 336 |
| 10020867 | S | 109 | ||
| 10026723 | SQLPTLEQDGGTQNPVSSPGMSQELR | S | 1 | 350 |
| 10028024 | SQLPTLEQDGGTQNPVSSPGMSQELR | S | 1 | 350 |
| 10036957 | TMTTNSSDPFLNSGTYHSR | 376 | ||
| 10037533 | SQLPTLEQDGGTQNPVSSPGMSQELR | 366 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 5867 | MS | HTP | ambiguous | human | HeLa cells | 31373491 | ||||
| 10006090 | MS, site-directed mutagenesis | LTP | unambiguous | human | Bel-7402 cells, SMMC-7721 cells | 28474680 | ||||
| 10006105 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | ||||
| 10006106 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | ||||
| 10006107 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | This site was described as S334 of the protein sequence in the original paper | |||
| 10014834 | MS | HTP | unambiguous | human | HeLa cells | 31373491 | ||||
| 10014888 | MS | HTP | unambiguous | human | HeLa cells | 31373491 | ||||
| 10020867 | Site-specific mutagenesis | LTP | unambiguous | human | BCPAP, KTC-1, and TPC-1 cells | 34155345 | ||||
| 10026723 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10028024 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | ||||
| 10036957 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | ||||
| 10037533 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -2.321928095 | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5867 | QASTDAGTAGALTPQHVR | S | 3 | 109 | MS | HTP | ambiguous | human | HeLa cells | 31373491 | |
| 10006090 | AMLSQMNVTAPTSPPVQQNMMNSASGPLPDGWEQAMTQDGEIYYINHK | T | 37 | 241 | MS, site-directed mutagenesis | LTP | unambiguous | human | Bel-7402 cells, SMMC-7721 cells | 28474680 | |
| 10006105 | TANVPQTVPMR | T | 7 | 83 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | |
| 10006106 | QASTDAGTAGALTPQHVR | S | 3 | 109 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | |
| 10006107 | SQLPTLEQDGGT QNPVSSPGMSQELR | S | 1 | 350 | MS | LTP | unambiguous | human | HeLa cells | 29100056 | This site was described as S334 of the protein sequence in the original paper |
| 10014834 | TANVPQTVPMR | T | 7 | 83 | MS | HTP | unambiguous | human | HeLa cells | 31373491 | |
| 10014888 | NINPSTANSPK | S | 5 | 336 | MS | HTP | unambiguous | human | HeLa cells | 31373491 | |
| 10020867 | S | 109 | Site-specific mutagenesis | LTP | unambiguous | human | BCPAP, KTC-1, and TPC-1 cells | 34155345 | |||
| 10026723 | SQLPTLEQDGGTQNPVSSPGMSQELR | S | 1 | 350 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10028024 | SQLPTLEQDGGTQNPVSSPGMSQELR | S | 1 | 350 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | |
| 10036957 | TMTTNSSDPFLNSGTYHSR | 376 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | |||
| 10037533 | SQLPTLEQDGGTQNPVSSPGMSQELR | 366 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |